SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Konoplev S, Champlin RE, Giralt S, et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant. 2001; 27: 877881.
  • 2
    Nguyen Q, Estey E, Raad I, et al. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis. 2001; 32: 539545.
  • 3
    Salomon N, Perlman DC. Cytomegalovirus pneumonia. Semin Respir Infect. 1999; 14: 353358.
  • 4
    Kruger RM, Paranjothi S, Storch GA, Lynch JP, Trulock EP. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients. J Heart Lung Transplant. 2003; 22: 754763.
  • 5
    Manna A, Cordani S, Canessa P, Pronzato P. CMV infection and pneumonia in hematological malignancies. J Infect Chemother. 2003; 9: 265267.
  • 6
    Mera JR, Whimbey E, Elting L, et al. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: review of 20 cases occurring from 1964 through 1990. Clin Infect Dis. 1996; 22: 10461050.
  • 7
    Rosen P, Hajdu S. Cytomegalovirus inclusion disease at autopsy of patients with cancer. Am J Clin Pathol. 1971; 55: 749756.
  • 8
    Casazza AR, Duvall CP, Carbone PP. Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA. 1966; 197: 710716.
  • 9
    Lundin J, Hagberg H, Repp R, et al. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome. Blood. 2003; 101: 42674272.
  • 10
    Nguyen DD, Cao TM, Dugan K, Starcher SA, Fechter RL, Coutre SE. Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia. Clin Lymphoma. 2002; 3: 105110.
  • 11
    Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002; 34: 10941097.
  • 12
    Daniel WW. The chi-square distribution and the analysis of frequencies. In: DanielWW, editor. Biostatistics: a foundation for analysis in the health sciences. 7th ed. New York: John Wiley & Sons, 1999: 606607.
  • 13
    Duvall CP, Casazza AR, Grimley PM, Carbone PP, Rowe WP. Recovery of cytomegalovirus from adults with neoplastic disease. Ann Intern Med. 1966; 64: 531541.
  • 14
    Bowden RA. Antivirals for CMV. Amsterdam: Elsevier, 1993.
  • 15
    Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol. 1985; 21: 217221.
  • 16
    Ljungman P. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Semin Respir Infect. 1995; 10: 209215.
  • 17
    Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005; 84: 112.
  • 18
    de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol. 2002; 25(Suppl. 2): S112.
  • 19
    Riddell SR. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect. 1995; 10: 199208.
  • 20
    Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol. 1990; 17: 673682.
  • 21
    Wood GS, Edinger A, Hoppe RT, Warnke RA. Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype. J Cutan Pathol. 1994; 21(2): 151156.
  • 22
    Myerson D, Hackman RC, Meyers JD. Diagnosis of cytomegaloviral pneumonia by in situ hybridization. J Infect Dis. 1984; 150: 272277.
  • 23
    Tamm M, Traenkle P, Grilli B, et al. Pulmonary cytomegalovirus infection in immunocompromised patients. Chest. 2001; 119: 838843.
  • 24
    Emanuel D, Peppard J, Stover D, Gold J, Armstrong D, Hammerling U. Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann Intern Med. 1986; 104: 476481.
  • 25
    Crawford SW, Bowden RA, Hackman RC, Gleaves CA, Meyers JD, Clark JG. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med. 1988; 108: 180185.
  • 26
    Goldstein LC, McDougall J, Hackman R, Meyers JD, Thomas ED, Nowinski RC. Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun. 1982; 38: 273281.
  • 27
    Chemaly RF, Yen-Lieberman B, Castilla EA, et al. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol. 2004; 42: 21682172.
  • 28
    Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J Infect Dis. 1990; 162: 373380.
  • 29
    Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis. 1988; 10(Suppl. 3): S460467.
  • 30
    Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002; 100: 43584366.
  • 31
    Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis. 1998; 26: 753755.
  • 32
    Crumpacker C, Marlowe S, Zhang JL, Abrams S, Watkins P. Treatment of cytomegalovirus pneumonia. Rev Infect Dis. 1988; 10(Suppl. 3): S538546.